Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9602261rdf:typepubmed:Citationlld:pubmed
pubmed-article:9602261lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C0679729lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C0553580lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C0441772lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C0038953lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9602261lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:9602261pubmed:issue3lld:pubmed
pubmed-article:9602261pubmed:dateCreated1998-7-23lld:pubmed
pubmed-article:9602261pubmed:abstractTextIn the multicenter European Intergroup Cooperative Ewing's Sarcoma Studies, localized Ewing tumors of bone were treated by combination chemotherapy with surgery and/or radiotherapy. Patients with primary metastases (pm-pts) were treated in high risk protocols.lld:pubmed
pubmed-article:9602261pubmed:languageenglld:pubmed
pubmed-article:9602261pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9602261pubmed:citationSubsetIMlld:pubmed
pubmed-article:9602261pubmed:statusMEDLINElld:pubmed
pubmed-article:9602261pubmed:monthMarlld:pubmed
pubmed-article:9602261pubmed:issn0923-7534lld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:WinkelmannWWlld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:FröhlichBBlld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:JürgensHHlld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:AhrensSSlld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:BurdachSSlld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:ZoubekAAlld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:DunstJJlld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:Dockhorn-Dwor...lld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:CraftAAlld:pubmed
pubmed-article:9602261pubmed:authorpubmed-author:PaulussenMMlld:pubmed
pubmed-article:9602261pubmed:issnTypePrintlld:pubmed
pubmed-article:9602261pubmed:volume9lld:pubmed
pubmed-article:9602261pubmed:ownerNLMlld:pubmed
pubmed-article:9602261pubmed:authorsCompleteYlld:pubmed
pubmed-article:9602261pubmed:pagination275-81lld:pubmed
pubmed-article:9602261pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:meshHeadingpubmed-meshheading:9602261-...lld:pubmed
pubmed-article:9602261pubmed:year1998lld:pubmed
pubmed-article:9602261pubmed:articleTitlePrimary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.lld:pubmed
pubmed-article:9602261pubmed:affiliationDepartment of Pediatric Oncology, University of Münster, Germany. paulusm@uni-muenster.delld:pubmed
pubmed-article:9602261pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9602261pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9602261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9602261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9602261lld:pubmed